3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
3
Urinary Bladder Neoplasms
1
Tobacco Use Disorder
1
Sunburn
1
Stress, Psychological
1
Stress Disorders, Post-Traumatic
1
Smoking Cessation
1
Prostatic Hyperplasia
1
Motor Activity
1
Melanoma
1
Head and Neck Neoplasms
1
Depression
1
Anxiety Disorders
1
Alzheimer Disease
1
Acquired Immunodeficiency Syndrome
1
Interventions
Tobacco Use Cessation Devices
6
Counseling
4
Varenicline
3
Nicotine Replacement Therapy
3
Early Intervention, Educational
3
Community Health Workers
3
Bupropion
3
Nicotine
2
Aspirin
2
zileuton
1
phenethyl isothiocyanate
1
Zinc Oxide
1
X-Rays
1
Surveys and Questionnaires
1
Sulindac
1
Spectrometry, Fluorescence
1
Risk Factors
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Optical Imaging
1
Nicotine Chewing Gum
1
Molecular Diagnostic Techniques
1
Methods
1
Memantine
1
Gene Expression Profiling
1
Focus Groups
1
Fertility
1
Ethanol
1
Endoscopic Mucosal Resection
1
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Tobacco Use Disorder
×
Amyloid
×
Clear all
NCT06883097
2025-12-17
QMH
Wake Forest University Health Sciences
Phase NA
Recruiting
314 enrolled